Indeed, in previous tissue-based studies the ratio of STAT1:STAT3 in tumor cells was highly prognostic in CRC, and in prostate cancer loss of STAT1 associated with increased recurrence [32, 33]. This evidence concerns the gene STAT1 and prostate carcinoma.